Most Read Articles
4 days ago
Prenatal and postpartum vitamin D supplementation does not appear to improve foetal or infant growth, a study reports.
6 days ago
Excessive daytime sleepiness appears to increase the long-term risk of amyloid β (Aβ) deposition, a recent study has shown.
6 days ago
Substituting diets high in carbohydrates with those high in monounsaturated fatty acids in the context of low saturated fatty acids do not appear to yield favourable effects on blood pressure, according to a meta-analysis.
12 Sep 2018
Among obese and overweight adults with type 2 diabetes mellitus, women appear to be less likely than men to develop mild cognitive impairment, independent of traditional risk factors, a recent study has shown.

Factors associated with increased mortality in AMD

05 Dec 2017

Survival in age-related macular degeneration (AMD) may be reduced in patients with late disease, bilateral cataract surgery and poor visual acuity, according to data from the Age-Related Eye Disease Study 2 (AREDS2). Moreover, oral supplementation with omega-3 fatty acids, lutein plus zeaxanthin, zinc or beta-carotene does not significantly affect mortality.

AREDS2 randomized 4,203 patients with at least intermediate AMD to receive lutein/zeaxanthin and/or omega-3 fatty acids for treatment of AMD and cataract. Baseline and annual assessments included best-corrected visual acuity (BCVA), slit-lamp examinations and stereoscopic fundus photographs that were centrally graded for development of late AMD (central geographic atrophy or neovascular AMD) or pseudophakia.

Of the patients, 368 died during a median follow-up of 5 years. In Cox proportional hazards models, mortality was elevated in patients with neovascular AMD in one eye at baseline than in those with no or few drusen (hazard ratio [HR], 1.56; 95 percent CI, 1.21 to 2.01; p<0.001).

Survival was also poor for patients with bilateral cataract surgery before enrolment than for those with baseline bilateral phakia (HR, 1.63; 1.29 to 2.07; p<0.001), as well as for patients with BCVA of <20/40 vs those with ≥20/40 (HR, 1.56; 1.06 to 2.30; p=0.024).

On the other hand, mortality was lower in patients who received antivascular endothelial growth factor therapies for neovascular AMD than in those who did not (HR, 0.71; 0.57 to 0.88; p=0.002).

The association between all-cause mortality and AREDS2 treatment did not significantly differ whether assessing the main or individual treatment effect (omega-3 fatty acids main effect: HR, 1.18; 0.96 to 1.45; p=0.12; lutein/zeaxanthin main effect: HR, 1.04; 0.85 to 1.28; p=0.71).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
4 days ago
Prenatal and postpartum vitamin D supplementation does not appear to improve foetal or infant growth, a study reports.
6 days ago
Excessive daytime sleepiness appears to increase the long-term risk of amyloid β (Aβ) deposition, a recent study has shown.
6 days ago
Substituting diets high in carbohydrates with those high in monounsaturated fatty acids in the context of low saturated fatty acids do not appear to yield favourable effects on blood pressure, according to a meta-analysis.
12 Sep 2018
Among obese and overweight adults with type 2 diabetes mellitus, women appear to be less likely than men to develop mild cognitive impairment, independent of traditional risk factors, a recent study has shown.